2006 annual financial data

Corcept Therapeutics 2006 Net margin

Corcept Therapeutics 2006 net margin with verified reported values.

Direct answer

Net margin was -8,460.2%.

Operating income was -25,582,000 USD and net income was -24,873,000 USD.
Operating cash flow was -23,238,000 USD.

Get free Corcept Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
294,000 USD
Operating income
-25,582,000 USD
Net income
-24,873,000 USD
Operating cash flow
-23,238,000 USD